Regulatory tracker: FDA clears GSK’s Benlysta autoinjector in kids with lupus nephritis

In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Some of these updates may not meet the bar for standalone stories, but we think they are still worth mentioning.

Jun 24, 2025 - 16:25
 0
Regulatory tracker: FDA clears GSK’s Benlysta autoinjector in kids with lupus nephritis
In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Some of these updates may not meet the bar for standalone stories, but we think they are still worth mentioning.